GWN-323

N/A

Report date: 2025/03/03 20:00:49

Base Information

Drug NameGWN-323
Drug Alias NameGWN-323
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein agonists
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[6] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsSolid tumoursLymphoma

Other Information

ATC CodeN/A
Related LinksN/A